Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cyclopharm Capital Raising Presentation (ASX:CYC)

To view the presentation, download the attached PDF.

Cyclopharm Successfully Completes A$30 Million Placement (ASX:CYC)

Cyclopharm Limited (“CYC” or the “Company”) is pleased to announce it has successfully completed a share placement (“Placement”) to institutional and sophisticate...read more

Cyclopharm - SNMMI Requests USFDA to Expedite Approval For Technegas (ASX:CYC)

Cyclopharm Limited (ASX: CYC) (“Cyclopharm” or “the Company”) notes the publication by the US based Society of Nuclear Medicine and Molecular Imaging (SNMMI) of a letter to t...read more

Cyclopharm - Trading Halt (ASX:CYC)

The securities of Cyclopharm Limited (‘CYC’) will be placed in trading halt at the request of CYC, pending it releasing an announcement. Unless ASX decides otherwise, the securities will...read more

Cyclopharm - USFDA Approval Progress for Technegas and Business Update (ASX:CYC)

Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its progress towards gaining United States Food and Drug Administration (“USFDA”) approval to begin sales of T...read more

Cyclopharm Investor Presentation (ASX:CYC)

To view the presentation, download the attached PDF.

Cyclopharm Announces Technegas USA Trial Successfully Meets Primary Endpoint (ASX:CYC)

Radiopharmaceutical company, Cyclopharm Limited (ASX: CYC) is pleased to confirm that an independent Data Monitoring Efficacy Committee (DEMC), requested by the USFDA as part of its assessment...read more

Cyclopharm - Half Year 2020 Financial Results (ASX:CYC)

Radiopharmaceutical company, Cyclopharm Limited (ASX:CYC) today announced financial report for the six month period to 30 June 2020, including sales revenue of $5.8 million, in line with previ...read more

Cyclopharm - Half Yearly Report and Accounts (ASX:CYC)

Please see attached 30 June 2020 Half Year Report for Cyclopharm Limited (ASX - CYC). This announcement is made pursuant to Listing Rule 4.2A.3. For more information, download the attach...read more

Cyclopharm - Dividend/Distribution (ASX:CYC)

To view the Notification of dividend / distribution, download the attached PDF.

Cyclopharm 1H2020 Business Update (ASX:CYC)

Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its business performance during the first half of financial year 2020, including progress towards gaining United States Fo...read more

USFDA Approval to File Received for Technegas (ASX:CYC)

TECHNEGASTM – USFDA NEW DRUG APPLICATION APPROVAL – NEXT MILESTONE IN APPROVAL PROCESS SUCCESSFULLY ACHIEVED : APPROVAL TO FILE NOTIFICATION RECEIVED TECHNEGAS AP...read more

Cyclopharm Technegas Approved in Russia (ASX:CYC)

Cyclopharm Limited (ASX: CYC) is pleased to announce that it has gained regulatory approval to sell its Technegas products in Russia; furthermore, the Company has secured its first order for a Tech...read more

USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver (ASX:CYC)

Cyclopharm Limited (ASX: CYC) is pleased to announce that the United States Food and Drug Administration(USFDA) has granted the Company a full application fee waiver of USD $2.9m related to its rece...read more

Cyclopharm (ASX:CYC) Company Update (ASX:CYC)

COVID-19 Virus likely to increase use of Technegas® US FDA New Drug Application for Technegas – Application ready to submit to FDA Litigation – Statement of Claim Lodged with th...read more

Viewing: 16 - 30 of 42 Previous | Next